Drupal.behaviors.print = function(context) {window.print();window.close();}>
UNC Analysis Finds Beta1-AR Alleles Impact Survival in Patients Treated with Beta-Blockers
April 04, 2012
UNC Analysis Finds Beta1-AR Alleles Impact Survival in Patients Treated with Beta-Blockers
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
After Decade as CRO, Shanghai Biochip Plans Move into Chinese Molecular Dx Market
December 18, 2012 / BioArray News
PGx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 14, 2012 / Pharmacogenomics Reporter
GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor
With Celgene Partnership Epizyme Hopes to Accelerate Personalized Epigenetic Drug Development
May 16, 2012 / Pharmacogenomics Reporter
NHLBI Funds UNC Diabetes PGx Project
May 1, 2012 / GenomeWeb Daily News